UK Architects RMJM To Design $90m Biotech Facility In Beijing

UK architecture firm RMJM has been appointed design architect for a state-of-the-art $US90 million biotechnology research and development centre in Beijing , it was announced recently. The new facility is for Genzyme Corp. The facility is to be built at Zhongguancun (ZGC) Life Science Park which is dedicated to academic and government research centres as well as pharmaceutical and biotechnology companies.

http://www.medicalnewstoday.com/articles/106819.php